First, it started in Australia. Now it's coming to the U....

First, it started in Australia. Now it's coming to the U.S. and guess who is funding the Vaxxas vaccine patch? "The HHS Biomedical Advanced Research and Development Authority has awarded Vaxxas $22 million to conduct phase 1 studies of its COVID-19 vaccine patch. The phase 1...See more

Vaxxas Receives $22 Million from HHS for Vaccine Patch Studies

The patch has “shown the potential to transform vaccine delivery with lower dose requirements, enabling more patient-doses to be manufactured more quickly from limited vaccine supply,” the company said.

fdanews.com

Oct 13 2020 · 8:42 PM

7upvotes

1remind